Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 30,420 shares at $91.66 ($2.8M) on 2020-02-25, disclosed to the SEC on 2020-02-27.
Open-market sale of $2.8M RGEN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.22 | 1,624 | $147K | 5.3% |
| 2 | $90.22 | 1,624 | $147K | 5.3% |
| 3 | $91.66 | 8,412 | $771K | 28.0% |
| 4 | $91.66 | 8,412 | $771K | 28.0% |
| 5 | $92.34 | 1,699 | $157K | 5.7% |
| 6 | $92.34 | 1,699 |
| $157K |
| 5.7% |
| 7 | $86.10 | 1,594 | $137K | 5.0% |
| 8 | $86.10 | 1,594 | $137K | 5.0% |
| 9 | $86.86 | 1,881 | $163K | 5.9% |
| 10 | $86.86 | 1,881 | $163K | 5.9% |
| Total | $90.41 avg | 30,420 | $2.8M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |